NODAL and pancreatic neoplasm: We further demonstrated that blockade of Nodal signaling activity by SB431542 administration significantly reduces the number and size of liver metastases from human pancreatic cancer cells in a reliable experimental metastasis model but has very little effect on primary tumor growth.